Renal denervation for resistant hypertension

CONCLUSIONS: In patients with resistant hypertension, there is low-certainty evidence that renal denervation does not improve major cardiovascular outomes and renal function. Conversely, moderate-certainty evidence exists that it may improve 24h ABPM and diastolic office-measured BP. Future trials measuring patient-centred instead of surrogate outcomes, with longer follow-up periods, larger sample size and more standardised procedural methods are necessary to clarify the utility of this procedure in this population.PMID:34806762 | DOI:10.1002/14651858.CD011499.pub3
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Source Type: research

Related Links:

Journal of Human Hypertension, Published online: 27 January 2022; doi:10.1038/s41371-021-00651-zMalignant hypertension and atypical hemolytic uremic syndrome: a possible continuum between two entities?
Source: Journal of Human Hypertension - Category: Cardiology Authors: Source Type: research
Journal of Human Hypertension, Published online: 27 January 2022; doi:10.1038/s41371-021-00652-yFocus on today’s evidence while keeping an eye on the future: lessons derived from hypertension in women
Source: Journal of Human Hypertension - Category: Cardiology Authors: Source Type: research
HIGH cholesterol occurs when you have too much of a fatty substance called cholesterol in your blood. The build-up of this substance can cause a blockage in your blood vessels, leading to heart problems and stroke. New research shares the "hedonically acceptable snacks" which can lower high levels in just weeks.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Palihapitiya-Led SPAC to Merge With Akili in $1 Billion Deal (Bloomberg): Akili Interactive, a startup that has developed a video game to help treat attention-deficit disorders in kids, has agreed to go public through a merger with one of Chamath Palihapitiya’s blank-check companies. The deal, which confirms a Bloomberg News report, values the combined entity at about $1 billion, Akili and Social Capital Suvretta Holdings Corp. I said in a statement seen by Bloomberg. It will provide as much as $412 million in gross cash proceeds, the companies said. Led by Chief Executive Officer Eddie Martucci, Akili has developed ...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Attention & ADD/ADHD Brain/ Mental Health Technology & Innovation Akili Interactive attention deficit hyperactivity disorder Chamath Palihapitiya cognitive-impairments digital therapeutics EndeavorRx FDA neuropsychiatric neuropsychia Source Type: blogs
Conditions:   Pulmonary Arterial Hypertension;   Erectile Dysfunction Intervention:   Drug: TPN171H single dose Sponsors:   Vigonvita Life Sciences;   Shanghai Institute of Materia Medica, Chinese Academy of Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Hypertension Intervention:   Behavioral: Adherence Sponsor:   Pham Ngoc Thach University of Medicine Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Acute Ischemic Stroke Intervention:   Other: telephone call d90 Sponsor:   Xuanwu Hospital, Beijing Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Peripheral Nerve Injury Upper Limb;   Healthy Intervention:   Other: STEGA-MRI Sponsors:   Washington University School of Medicine;   National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Stroke Patients Intervention:   Diagnostic Test: Bone mineral density Sponsor:   Hitit University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Muscular Dystrophy, Duchenne Intervention:   Sponsor:   Hacettepe University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Chia | Clinical Trials | Databases & Libraries | General Medicine | Heart | Heart Attack | Hyperactivity | Hypertension | International Medicine & Public Health | Ischemic Stroke | Reflex Sympathetic Dystrophy | Statistics | Stroke | Study | Urology & Nephrology | WHO